OBJECTIVE: To determine whether a multimedia computer program could effectively teach patients about fecal occult blood testing (FOBT)
and increase screening rates.
DESIGN: Randomized trial.
SETTING: University-affiliated, community-based Internal Medicine outpatient practice.
PARTICIPANTS: All English-speaking patients aged 50 years and older who were offered FOBT screening by their providers were invited to
participate. Two hundred and four patients enrolled in the study. Ten patients were later determined to be ineligible.
INTERVENTIONS: Patients were randomized to either the educational multimedia computer program or usual nurse counseling about FOBT screening.
Screening instructions were based on the material pre-printed on each test kit. Educational sessions were held in a private
setting immediately after each patient’ office visit.
MEASUREMENTS AND MAIN RESULTS: A knowledge-assessment questionnaire was administered in a blinded fashion by telephone the following day. Successful screening
was defined as return of the test kits within 30 d. Completion of the FOBT kits was similar in both groups: 62% (58/93) in
the computer group and 63% (64/101) in the nurse group (P=.89). Mean knowledge scores were also similar, but there was a trend toward increased knowledge mastery in the computer group
(56% vs 41%, P=.09).
CONCLUSIONS: A multimedia educational computer program was as effective as usual nurse counseling in educating patients and achieving
adherence to FOBT screening. Future studies are needed to determine whether computer-assisted instruction can improve health
outcomes.
Key Words computer-assisted instruction - colorectal neoplasms - mass screening - patient education - occult blood
The authors have no conflicts of interest pertaining to this study.
Preliminary results of this study were presented at the Society of General Internal Medicine 26th Annual Meeting, May 2, 2003,
Vancouver, British Columbia.
Partial funding for this research was obtained through developmental funds from the Cancer Center Core Grant of the Comprehensive
Cancer Center of Wake Forest University, P30 CA 12197. Beckman Coulter, Inc., supplied the Hemoccult Sensa II patient test
kits.